Clinical Chemistry
Main Filters
Clinical Chemistry
CLINICAL DIAGNOSTIC SOLUTIONS, INC. | ||||
CATALOG # | QTY | PRICE | DESCRIPTION | |
501-416 | 0 | - | ||
501-418 | 0 | - | ||
501-419 | 0 | - | ||
501-420 | 0 | - | ||
501-444 | 0 | - |
EXACT DIAGNOSTICS, LLC | ||||
CATALOG # | QTY | PRICE | DESCRIPTION | |
ADVH102 | 0 | - | ||
ADVL101 | 0 | - | ||
ADVP100 | 0 | - | ||
BKVH102 | 0 | - | ||
BKVL101 | 0 | - | ||
BKVP100 | 0 | - | ||
CMVH102 | 0 | - | ||
CMVL101 | 0 | - | ||
CMVP100 | 0 | - | ||
EBVH102 | 0 | - | ||
EBVL101 | 0 | - | ||
EBVP100 | 0 | - | ||
HBVAMR | 0 | - | ||
HBVH102 | 0 | - | ||
HBVL101 | 0 | - | ||
HBVP100 | 0 | - | ||
HCVAMR | 0 | - | ||
HCVH102 | 0 | - | ||
HCVL101 | 0 | - | ||
HCVP100 | 0 | - | ||
HIVAMR | 0 | - | ||
HIVH102 | 0 | - | ||
HIVL101 | 0 | - | ||
HIVP100 | 0 | - | ||
HPV16C | 0 | - | ||
HPV18C | 0 | - | ||
HPV68C | 0 | - | ||
HPVNEG | 0 | - | ||
HSV1H102 | 0 | - | ||
HSV1L101 | 0 | - | ||
HSV1P100 | 0 | - | ||
HSV2L101 | 0 | - | ||
HSV2P100 | 0 | - | ||
HV6AP100 | 0 | - | ||
HV6BP100 | 0 | - | ||
HV6H102 | 0 | - | ||
HV6L101 | 0 | - | ||
NEG000 | 0 | - | ||
NEG050 | 0 | - | ||
VZVH102 | 0 | - | ||
VZVL101 | 0 | - | ||
VZVP100 | 0 | - | ||
ZKVH102 | 0 | - | ||
ZKVL101 | 0 | - | ||
ZKVP100 | 0 | - |
19,621 Results
Results Per Page
- 50
- 100
- 250
Catalog #
AvailableQty
Starting At
Name
Company Name
Description
0
-
Direct TIBC Reagent Set
CLINICAL DIAGNOSTIC SOLUTIONS, INC.
For use in the determination of total iron-binding capacity in serum on automated chemistry analyzers. For in vitro diagnostic use only. Total iron-binding capacity (TIBC) is the measure of the ability of serum proteins, principally transferrin, to bind iron. It is the maximum concentration of iron that the serum proteins can bind.Together with the total serum iron concentration, the TIBC is used in the diagnosis and treatment of iron deficiency anemia, other disorders of iron metabolism, and chronic inflammatory disorders. As an index of nutritional status, Serum TIBC is increased in iron deficiency, and decreased in anemia that is due to chronic disease.
0
-
LDL Cholesterol Reagent Set
CLINICAL DIAGNOSTIC SOLUTIONS, INC.
The LDL-Cholesterol Reagent Set is intended for the in vitro quantitative determination of Low Density Lipoprotein Cholesterol in human serum or plasma. The reagents can assist in the diagnosis and treatment of patients at risk of developing coronary heart disease. Elevated LDL cholesterol is the primary target of cholesterol-lowering therapy.
0
-
HDL Cholesterol Reagent Set
CLINICAL DIAGNOSTIC SOLUTIONS, INC.
The HDL-Cholesterol Reagent Set is intended for the in vitro quantitative determination of High Density Lipoprotein Cholesterol in human serum or plasma. The reagent can assist in the diagnosis and treatment of patients at risk for developing coronary heart disease.
0
-
Uric Acid Reagent
CLINICAL DIAGNOSTIC SOLUTIONS, INC.
For the quantitative determination of Uric Acid in serum. For in vitro diagnostic use only. The determination of uric acid in serum is most commonly performed for the diagnosis of gout. Increased uric acid levels are also found in leukemia, polycythemia, familial idiopathic hyperuricemia, and conditions associated with decreased renal function.
0
-
Total Protein Reagent
CLINICAL DIAGNOSTIC SOLUTIONS, INC.
For the quantitative determination of total protein concentration in serum.